한글목차

건선성 관절염 치료 동향 및 전망

세계 건선성 관절염 치료 시장은 2024년부터 2030년까지 9.6%의 CAGR로 2030년까지 약 157억 7,000만 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 노인 인구의 증가와 건선성 관절염의 유병률 증가, 제품 수요 증가입니다. 건선성 관절염 치료에 대한 지식의 증가와 더불어 건선성 관절염 치료에 대한 신약, 생물학적 제제 및 바이오시밀러 의약품의 강력한 파이프라인을 제공하기 위해 건선성 관절염 치료에 대한 연구 개발 활동이 급증하고 있습니다. 세계 건선성 관절염 치료 시장의 미래는 병원 약국, 소매 약국 및 온라인 약국 시장에서 기회가 있고 유망해 보입니다.

건선성 관절염 치료 시장에 대한 인사이트

Lucintel은 생물학적 질환 조절 항류마티스제는 질병 관리의 효과로 인해 생물학적 치료제의 사용이 증가함에 따라 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상했습니다.

아시아태평양은 건선성 관절염 발생률과 제네릭 의약품의 증가로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

자주 묻는 질문

Q1. 건선성 관절염 치료의 시장 규모는 어느 정도입니까?

A1. 세계 건선성 관절염 치료 시장은 2030년까지 약 157억 7,000만 달러에 달할 것으로 예상됩니다.

Q2. 건선성 관절염 치료 시장의 성장 전망은 어느 정도입니까?

A2. 세계 건선성 관절염 치료 시장은 2024년부터 2030년까지 연평균 9.6%의 성장률을 보일 것으로 예상됩니다.

Q3. 건선성 관절염 치료 시장의 성장에 영향을 미치는 주요 요인은 무엇인가?

A3. 이 시장의 주요 촉진요인은 노인 인구의 증가와 건선성 관절염의 유병률 증가, 건선성 관절염을 치료하는 제품에 대한 수요 증가입니다. 건선성 관절염 치료에 대한 연구 개발 노력이 급증하고 있으며, 건선성 관절염 치료에 대한 지식이 증가함에 따라 건선성 관절염에 대한 신약, 생물학적 제제 및 바이오시밀러 의약품의 강력한 파이프라인을 제공하기 위한 연구 개발 활동이 급증하고 있습니다.

Q4. 시장의 주요 부문은?

A4. 건선성 관절염 치료 시장의 미래는 병원 약국, 소매 약국, 온라인 약국 시장에서 기회가 있고 유망해 보입니다.

Q5. 시장의 주요 기업은?

A5. 주요 건선성 관절염 치료는 다음과 같습니다.

• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson & Johnson Services
• Eli Lilly and Company
• AstraZeneca
• Sanofi
• Bristol-Myers Squibb Company
• GlaxoSmithKline

Q6. 향후 가장 큰 시장 부문은?

A6. Lucintel은 생물학적 질환 조절 항류마티스제는 질병 관리의 효과로 인해 생물학적 치료제의 사용이 증가함에 따라 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상했습니다.

Q7. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은 어디인가?

A7. 아시아태평양은 건선성 관절염 발생률과 제네릭 의약품의 증가로 인해 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

Q8. 보고서 사용자 정의가 가능합니까?

A8. 예, Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 건선성 관절염 치료 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 건선성 관절염 치료 시장 동향(2018-2023년)과 예측(2024-2030년)
• 의약품 클래스별 세계의 건선성 관절염 치료 시장
  • 비스테로이드성 항염증제
  • 비생물학적 질병 완화 항류마티스제
  • 생물학적 질병 완화 항류마티스제
  • 기타
• 투여 경로별 세계의 건선성 관절염 치료 시장
  • 경구
  • 비경구
  • 외용
• 유통 채널별 세계의 건선성 관절염 치료 시장
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 건선성 관절염 치료 시장
• 북미의 건선성 관절염 치료 시장
• 유럽의 건선성 관절염 치료 시장
• 아시아태평양의 건선성 관절염 치료 시장
• 기타 지역의 건선성 관절염 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 의약품 클래스별 세계의 건선성 관절염 치료 시장 성장 기회
  • 투여 경로별 세계의 건선성 관절염 치료 시장 성장 기회
  • 유통 채널별 세계의 건선성 관절염 치료 시장 성장 기회
  • 지역별 세계의 건선성 관절염 치료 시장 성장 기회
• 세계의 건선성 관절염 치료 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 건선성 관절염 치료 시장 능력 확대
  • 세계의 건선성 관절염 치료 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson & Johnson Services
• Eli Lilly and Company
• AstraZeneca
• Sanofi
• Bristol-Myers Squibb Company
• GlaxoSmithKline

영문목차

Psoriatic Arthritis Treatment Trends and Forecast

The future of the global psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets. The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.

A more than 150-page report is developed to help in your business decisions.

Psoriatic Arthritis Treatment by Segment

The study includes a forecast for the global psoriatic arthritis treatment by drugs class, route of administration , distribution channel, and region.

Psoriatic Arthritis Treatment Market by Drugs Class [Shipment Analysis by Value from 2018 to 2030]:

• Non-steroidal Anti-inflammatory Drugs
• Non-biologic Disease Modifying Anti-Rheumatic Drugs
• Biologic Disease Modifying Anti-Rheumatic Drugs
• Others

Psoriatic Arthritis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Parenteral
• Topical

Psoriatic Arthritis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Psoriatic Arthritis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Psoriatic Arthritis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies psoriatic arthritis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the psoriatic arthritis treatment companies profiled in this report include-

• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson & Johnson Services
• Eli Lilly And Company
• Astrazeneca
• Sanofi
• Bristol-Myers Squibb Company
• Glaxosmithkline

Psoriatic Arthritis Treatment Market Insights

Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.

APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.

Features of the Global Psoriatic Arthritis Treatment Market

Market Size Estimates: Psoriatic arthritis treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Psoriatic arthritis treatment market size by drugs class, route of administration , distribution channel, and region in terms of value ($B).

Regional Analysis: Psoriatic arthritis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drugs class, route of administration , distribution channel, and regions for the psoriatic arthritis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the psoriatic arthritis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the psoriatic arthritis treatment market size?

Answer: The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030.

Q.2 What is the growth forecast for psoriatic arthritis treatment market?

Answer: The global psoriatic arthritis treatment market is expected to grow with a CAGR of 9.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the psoriatic arthritis treatment market?

Answer: The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.

Q4. What are the major segments for psoriatic arthritis treatment market?

Answer: The future of the psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key psoriatic arthritis treatment market companies?

Answer: Some of the key psoriatic arthritis treatment companies are as follows.

• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson & Johnson Services
• Eli Lilly and Company
• AstraZeneca
• Sanofi
• Bristol-Myers Squibb Company
• GlaxoSmithKline

Q6. Which psoriatic arthritis treatment market segment will be the largest in future?

Answer: Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.

Q7. In psoriatic arthritis treatment market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the psoriatic arthritis treatment market by drugs class (non-steroidal anti-inflammatory drugs, non-biologic disease modifying anti-rheumatic drugs, biologic disease modifying anti-rheumatic drugs, and others), route of administration (oral, parenteral, and topical), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Psoriatic Arthritis Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Psoriatic Arthritis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Psoriatic Arthritis Treatment Market by Drugs Class
  • 3.3.1: Non-steroidal Anti-inflammatory Drugs
  • 3.3.2: Non-biologic Disease Modifying Anti-Rheumatic Drugs
  • 3.3.3: Biologic Disease Modifying Anti-Rheumatic Drugs
  • 3.3.4: Others
• 3.4: Global Psoriatic Arthritis Treatment Market by Route of Administration
  • 3.4.1: Oral
  • 3.4.2: Parenteral
  • 3.4.3: Topical
• 3.5: Global Psoriatic Arthritis Treatment Market by Distribution Channel
  • 3.5.1: Hospital Pharmacies
  • 3.5.2: Retail Pharmacies
  • 3.5.3: Online Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Psoriatic Arthritis Treatment Market by Region
• 4.2: North American Psoriatic Arthritis Treatment Market
  • 4.2.2: North American Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
• 4.3: European Psoriatic Arthritis Treatment Market
  • 4.3.1: European Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
  • 4.3.2: European Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
• 4.4: APAC Psoriatic Arthritis Treatment Market
  • 4.4.1: APAC Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
  • 4.4.2: APAC Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
• 4.5: ROW Psoriatic Arthritis Treatment Market
  • 4.5.1: ROW Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
  • 4.5.2: ROW Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Drugs Class
  • 6.1.2: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Route of Administration
  • 6.1.3: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Region
• 6.2: Emerging Trends in the Global Psoriatic Arthritis Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Psoriatic Arthritis Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Psoriatic Arthritis Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann-La Roche
• 7.2: Novartis
• 7.3: Amgen
• 7.4: Pfizer
• 7.5: Johnson & Johnson Services
• 7.6: Eli Lilly and Company
• 7.7: AstraZeneca
• 7.8: Sanofi
• 7.9: Bristol-Myers Squibb Company
• 7.10: GlaxoSmithKline